Growth Metrics

Medinotec (MDNC) Current Leases (2024 - 2026)

Medinotec posted quarterly Current Leases of $21868.0 for Q4 2025, down 22.5% year-on-year from $28217.0 in Q4 2024, and down 23.85% on a QoQ basis from $28716.0 in Q3 2025.

Medinotec (MDNC) has 2 years of Current Leases data on file, last reported at $21868.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 22.5% year-over-year to $21868.0; the trailing twelve-month figure through Nov 2025 stood at $21868.0 (down 22.5% YoY), and the FY2025 full-year result was $28060.0, up 15.4% from the prior year.
  • Current Leases for Q4 2025 stood at $21868.0, down from $28716.0 in the prior quarter.
  • Across five years, Current Leases topped out at $30028.0 in Q2 2025 and bottomed at $21868.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Medinotec - - 854,557.00 14,905.00

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 14,905.00
Nov 30, 2025 21,868.00
Aug 31, 2025 28,716.00
May 31, 2025 30,028.00
Feb 28, 2025 28,060.00
Nov 30, 2024 28,217.00
Aug 31, 2024 27,753.00
May 31, 2024 25,575.00
Feb 29, 2024 24,316.00